PRISM Mid-Day Movers: Stock Dilution and Cannabis Earnings Drive Indices Lower

Biomea Fusion Falls 32% on Stock Offering Despite Promising Obesity Data
Biomea Fusion Inc. (BMEA) dropped 31.72% to lead losses in the PRISM Emerging Global Healthcare Index after pricing a $40 million public offering of common stock and warrants at $2.00 per unit. The announcement came before this morning's report from Biomea, which included preclinical data for its next-generation oral GLP-1 receptor agonist candidate, BMF-650, which showed significant appetite suppression and weight loss in obese primates.

Aurora Cannabis Slides 20% Despite Record Revenue and Positive Free Cash Flow
Aurora Cannabis Inc. (ACB) declined 20.02% in the PRISM Emerging Cannabis Index following its fiscal year 2025 earnings release. Despite achieving record annual global medical cannabis revenue of $244.4 million and generating $9.9 million in positive free cash flow, the company reported a Q4 net loss of $17.2 million and mixed guidance for Q1 2026.

Other PRISM Mid-Day Movers:
? Plus Therapeutics, Inc. (PSTV) down 37.01%
? Galectin Therapeutics Inc. (GALT) up 24.48%
? Creative Medical Technology Holdings, Inc. (CELZ) up 19.62%

The post PRISM Mid-Day Movers: Stock Dilution and Cannabis Earnings Drive Indices Lower appeared first on PRISM MarketView.

COMTEX_466478108/2927/2025-06-18T13:00:34